C. Portlock - Concepedia

Author

C. Portlock

Memorial Sloan Kettering Cancer Center

Also Known As

C Portlock, C S Portlock, C. Portlock, C. S. Portlock, C.S Portlock, C.S. Portlock, CS Portlock, CS. Portlock

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Yale University City Of Hope National Medical Center Cornell University University of Chicago Medical Center

About

C. Portlock is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	960
2	Health Sciences	7	7	438
3	Engineering	1	1	161
4	Cell Biology	1	1	144
5	Critical Care Medicine	1	1	15

C. Portlock

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. Naomi R. Schechter, C. Portlock, Joachim Yahalom Journal of Clinical Oncology	1998	294
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. Harvey M. Golomb, Alice K. Jacobs, A Fefer, Journal of Clinical Oncology Hematological MalignancyBone Marrow FailureLaboratory HematologyMedicineMalignant Blood Disorder	1986	236
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients Julie Teruya‐Feldstein, Elizabeth Y. Chiao, D Filippa, Annals of Oncology Lymphoid NeoplasiaHeterogenous SpectrumCd20-negative Large-cell LymphomaHuman RetrovirusPlasmablastic Features	2004	205
The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL) Ariela Noy, Heiko Schöder, Mithat Gönen, Annals of Oncology Positron Emission TomographyLymphoid NeoplasiaEngineeringOncologic ImagingMedical Imaging	2009	161
Resistance to methotrexate due to gene amplification in a patient with acute leukemia. M. D. Carman, Jan H. Schornagel, R S Rivest, Journal of Clinical Oncology Gene AmplificationMixed-phenotype Acute LeukemiaGeneticsLeukemia CellsEpigenetics	1984	144
Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. Joachim Yahalom, Subhash C. Gulati, M Toia, Journal of Clinical Oncology	1993	128
Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease. Arica Hirsch, Nicholas Vander, David J. Straus, Journal of Clinical Oncology	1996	128
Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma Sewit Teckie, Shaohai Qi, Monica Chelius, Annals of Oncology	2017	78
Randomized Study of the Duration of Treatment With Interferon Alfa-2B in Patients With Hairy Cell Leukemia Harvey M. Golomb, Mark J. Ratain, A Fefer, JNCI Journal of the National Cancer Institute	1988	77
Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma Rony Schaffel, Cyrus V. Hedvat, Julie Teruya‐Feldstein, Annals of Oncology	2009	76

Page 1